NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition

NMR in Biomedicine

Volumn 18, Issue 3, 2005, Pages 143-162

  Bollard, Mary E ^a   Stanley, Elizabeth G ^a   Lindon, John C ^a   Nicholson, Jeremy K ^a   Holmes, Elaine ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Laboratory animals; Metabonomics; NMR; Physiological variation

Indexed keywords

DRUG PRODUCTS; GENES; MEDICAL IMAGING; MEDICINE; METABOLISM; NUCLEAR MAGNETIC RESONANCE; PHYSIOLOGY;

DATA SETS; GENOMICS; METABONOMICS; PROTEOMICS;

BIOMEDICAL ENGINEERING;

2 OXOGLUTARIC ACID; ACETAZOLAMIDE; CADMIUM; CARBON TETRACHLORIDE; CHLOROFORM; CITRIC ACID; DNA; ESTROGEN DERIVATIVE; HYDRAZINE; MERCURY CHLORIDE; SUCCINIC ACID; WATER; XENOBIOTIC AGENT;

ACCLIMATIZATION; AGING; ANALYTIC METHOD; BIOCHEMICAL COMPOSITION; CIRCADIAN RHYTHM; DATA ANALYSIS; DIET RESTRICTION; DIETARY INTAKE; DNA MODIFICATION; DRUG SAFETY; EXPERIMENTAL ANIMAL; GENDER; GENETIC MODEL; INTESTINE FLORA; METABOLISM; NONHUMAN; PATTERN RECOGNITION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SLEEP DEPRIVATION; SPECIES DIFFERENCE; STRAIN DIFFERENCE; STRESS; TEMPERATURE DEPENDENCE; URINALYSIS; WATER DEPRIVATION;

ALGORITHMS; ANIMALS; BODY FLUIDS; GENE EXPRESSION PROFILING; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PROTEOME; PROTEOMICS; URINALYSIS; URINE;

ANIMALIA;

EID: 19144371287     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/nbm.935     Document Type: Review

References (121)

1. Aardema MJ, MacGregor JT. Toxicology and genetic toxicology in the new era of 'toxicogenomics': impact of '-omics' technologies. Mutat. Res. 2002; 499(1): 13-25.
2. Cockerell GL, McKim JM, Vonderfecht SL. Strategic importance of research support through pathology. Toxicol. Pathol. 2002; 30(1): 4-7.
3. Lindon JC, Nicholson JK, Holmes E, Antti H, Bollard ME, Keun H, Beckonert O, Ebbels TM, Reily MD, Robertson D, Stevens GJ, Luke P, Breau AP, Cantor GH, Bible RH, Niederhauser U, Senn H, Schlotterbeck G, Sidelmann UG, Laursen SM, Tymiak A, Car BD, Lehman-McKeeman L, Colet JM, Loukaci A, Thomas C. Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol. Appl. Pharmac. 2003; 187(3): 137-146.
4. Bell JD, Sadler PJ, Morris VC, Levander OA. Effect of ageing and diet on proton NMR spectra of rat urine. Magn. Reson. Med. 1991; 17(2): 414-422.
5. 1H NMR spectroscopy of urine and pattern recognition. Anal. Biochem. 2001; 295: 194-202.
6. Phipps AN, Wright B, Stewart J, Wilson ID. Use of proton NMR for determining changes in metabolite excretion profiles induced by dietary changes in the rat. Pharm. Sci. 1997; 3: 143-146.
7. Gavaghan CL, Wilson ID, Nicholson JK. Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLSDA. FEBS Lett. 2002; 530: 191-196.
8. Nicholson JK, Wilson ID. Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat. Rev. Drug Discov. 2003; 8: 668-676.
9. 1H NMR spectroscopy. Anal. Biochem. 2001; 291: 17-26.
10. Holmes E, Nicholls AW, Lindon JC, Connor SC, Connelly JC, Haselden JN, Damment SJ, Spraul M, Neidig P, Nicholson JK. Chemometric models for toxicity classification based on NMR spectra of biofluids. Chem, Res. Toxicol. 2000; 13(6): 471-478.
11. 1H NMR spectroscopy of biological fluids. Prog. NMR Spectrasc. 1989; 21: 449-501.
12. Gartland KP, Bonner FW, Nicholson JK. Investigations into the biochemical effects of region-specific nephrotoxic lesions. Mol. Pharmac. 1989; 35(2): 242-250.
13. Beckwith-Hall BM, Nicholson JK, Nicholls AW, Foxall PJD, Lindon JC, Connor SC, Abdi M, Connelly J, Holmes E. Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Chem. Res. Toxicol. 1998; 11: 260-272.
14. Robertson DG, Reily MD, Lindon JC, Holmes E, Nicholson JK. Metabonomic Technology as a tool for rapid throughput in vivo toxicity screening. Compreh. Toxicol. 2002; 14: 583-610.
15. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999; 11: 1181-1189.
16. Nicholson JK, Connelly J, Lindon JC, Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 2002; 1(2): 153-161.
17. Raamsdonk LM, Teusink B, Broadhurst D, Zhang N, Hayes A, Walsh MC, Berden JA, Brindle KM, Kell DB, Rowland JJ, Westerhoff HV, van Dam K, Oliver SG. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat. Biotechnol. 2001; 19(1): 45-50.
18. Fiehn O. Metabolomics-the link between genotypes and phenotypes. Plant Mol. Biol. 2002; 48(1-2): 155-171.
19. Lindon JC, Holmes E, Bollard ME, Stanley EG, Nicholson JK. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers 2004; 9(1): 1-31.
20. 13C NMR spectroscopy of urine for metabonomic studies. Anal. Chem. 2002; 74(17): 4588-4593.
21. 1H NMR spectroscopy for drug metabolite detection and characterization: the identification of paracetamol metabolites in urine and bile. NMR Biomed. 1994; 7(7): 295-303.
22. 1H NMR studies of vertebrate blood and plasma. Biochem. J. 1983; 211(3): 605-615.
23. Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ. Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin. Chem. 1984; 30(3): 426-432.
24. 1H nuclear magnetic resonance spectroscopy. J. Pharm. Biomed. Anal. 1998; 17(1): 125-132.
25. Lindon JC, Holmes E, Nicholson JK. Pattern recognition methods and applications in biomedical magnetic resonance. Prog. NMR Spectrosc. 2001; 39(1): 1-40.
26. Lindon JC, Holmes E, Nicholson JK. So what's the deal with metabonomics? Anal. Chem. 2003; 75(17): 384A-391A.
27. Sanins SM, Nicholson JK, Elcombe C, Timbrell J. Hepatotoxin-induced hypertaurinuria: a proton NMR study, Arch. Toxicol. 1990; 64: 407-411.
28. 2H NMR spectroscopic studies on the metabolism and biochemical effects of 2-bromoethanamine in the rat. Biochem. Pharmac. 1995; 49(10): 1349-1359.
29. Nicholls AW, Nicholson JK, Haselden JN, Waterfield CJ. A metabonomic approach to the investigation of drug-induced phospholipidosis: a NMR spectroscopy and pattern recognition study. Biomarkers 2000; 5: 410-423.
30. Ebbels TMD, Keun HC, Beckonert O, Antti H, Bollard ME, Holmes E, Lindon JC, Nicholson JK. Toxicity classification from metabonomic data using a density superposition approach: 'CLOUDS'. Anal. Chim. Acta 2003; 490: 109-122.
31. Beckonert O, Bollard ME, Ebbels TMD, Keun HC, Antti H, Holmes E, Lindon JC, Nicholson JK. NMR-based metabonomic toxicity classification: hierachical cluster analysis and k-nearest neighbour approaches. Anal. Chim. Acta 2003; 490: 3-15.
32. Simko V, Michael S, Kelley RE. Predictive value of random sample urine bile acids corrected by creatinine in liver disease. Hepatology 1987; 7(1): 115-121.
33. Waterfield CJ, Turton JA, Scales MD, Timbrell JA. The correlation between urinary and liver taurine levels and between predose urinary taurine and liver damage. Toxicology 1993; 77(1-2): 1-5.
34. 1H NMR spectroscopy of urine combined with pattern recognition. NMR Biomed. 1998; 11(4-5): 235-244.
35. Clayton TA, Lindon JC, Everett JR, Charuel C, Hanton G, Le Net JL, Provost JP, Nicholson JK. An hypothesis for a mechanism underlying hepatotoxin-induced hypercreatinuria. Arch. Toxicol. 2003; 77: 208-217.
36. Beebe KR, Pell RJ, Seahsholt MB. Pattern recognition. In Chemometrics: a Practical Guide. Wiley: New York, 1998; 81-110.
37. Lindon JC, Nicholson JK, Wilson ID. Directly coupled HPLC-NMR and HPLC-NMR-MS in pharmaceutical research and development. J. Chromatogr B Biomed. Sci. Applic. 2000; 748(1): 233-258.
38. Dear GJ, Plumb RS, Sweatman BC, Parry PS, Roberts AD, Lindon JC, Nicholson JK, Ismail IM. Use of directly coupled ion-exchange liquid chromatography-mass spectrometry and liquid chromatography-nuclear magnetic resonance spectroscopy as a strategy for polar metabolite identification. J. Chromatogr. B. Biomed. Sci. Applic. 2000; 748(1): 295-309.
39. Dear GJ, Plumb RS, Sweatman BC, Ayrton J, Lindon JC, Nicholson JK, Ismail IM. Mass directed peak selection, an efficient method of drug metabolite identification using directly coupled liquid chromatography-mass spectrometry-nuclear magnetic resonance spectroscopy. J. Chromatogr B. Biomed. Sci. Applic. 2000; 748(1): 281-293.
40. Jackson JE. A User's Guide to Principal Components. Wiley: New York, 1991.
41. Eriksson L, Johansson E, Kettaneh-Wold H, Wold S. Introduction to Multi and Megavariate Analysis using Projection Methods (PCA & PLS). Umetrics: Umeå, 1999.
42. Jellum E, Bjornson I, Nesbakken R, Johansson E, Wold S. Classification of human cancer cells by means of capillary gas chromatography and pattern recognition analysis. J. Chromatogr. 1981; 217: 231-237.
43. Wold A, Albano C, Dunn WJ, Edlund U, Esbensen K, Geladi P, Hellberg S, Johansson E, Lindberg W, Sjöström M. Multivariate analysis in chemistry. In Chemometrics: Mathematics and Statistics in Chemistry, Kowalski BR (ed.). Reidel: Dordrecht, 1984.
44. Jones AR. Some observations on the urinary excretion of glycine conjugates by laboratory animals. Xenobiotica 1982; 12: 387-395.
45. Bollard ME, Keun H, Ebbels T, Beckonert O, Antti H, Lindon JC, Holmes E, Nicholson JK. Comparative metabonomics of differential species toxicity of hydrazine in the rat and mouse. Toxicol. Appl. Pharmac. accepted for publication.
46. Holmes E, Bonner FW, Nicholson JK. Comparative biochemical effects of low doses of mercury II chloride in the F344 rat and the Multimammate mouse (Mastomys natalensis). Comp. Biochem. Physiol. 1996; 114C(1): 7-15.
47. 1H NMR spectroscopic and histopathological studies on propyleneimine-induced renal papillary necrosis in the rat and the multimammate desert mouse (Mastomys natalensis). Comp. Biochem. Physiol. C. Pharmac. Toxicol. Endocrinol. 1997; 116(2): 125-134.
48. Weinberg JM, Harding PG, Humes HD. Mitochondrial bioenergetics during the initiation of mercuric chloride induced renal injury. J. Biol. Chem. 1982; 257: 60-67.
49. Holmes E, Bonner FW, Nicholson JK. Comparative studies on the nephrotoxicity of 2-bromoethanamine hydrobromide in the Fischer 344 rat and the multimammate desert mouse (Mastomys natalensis). Arch. Toxicol. 1995; 70(2): 89-95.
50. Carlton WW, Engelhardt JA. Experimental renal papilliary necrosis in the Syrian hamster. Food Chem. Toxicol. 1989; 27(5): 331-340.
51. Timbrell JA, Draper R, Waterfield CJ. Biomarkers in toxicology. Toxicol. Ecotoxicol. News 1994; 1(1): 4-14.
52. Griffin JL, Walker LA, Garrod S, Holmes E, Shore RE, Nicholson JK. NMR spectroscopy based metabonomic studies on the comparative biochemistry of the kidney and urine of the bank vole (Clethrionomys glareolus), wood mouse (Apodemus sylvaticus), white toothed shrew (Crocidura suaveolens) and the laboratory rat. Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 2000; 127(3): 357-367.
53. Costa C, DeAntoni A, Baccichetti F, Vanzan S, Appodia M, Allegri G. Strain differences in the tryptophan metabolite excretion and enzyme activities along the kynurenine pathway in rats. Ital. J. Biochem. 1982; 31(6): 412-418.
54. Costa C, DeAntoni A, Baccichetti F, Biasiolo M, Allegri G. Metabolites and enzyme activities involved in tryptophan metabolism in two strains of mouse. Ital. J. Biochem. 1984; 33(5): 319-324.
55. Ahmadizadeh M, Echt R, Kuo CH, Hook JB. Sex and strain differences in mouse kidney: Bowman's capsule morphology and susceptibility to chloroform. Toxicol. Lett. 1984; 20(2): 161-171.
56. Harstad EB, Klaassen CD. Analysis of strain difference in sensitivity to cadmium-induced hepatotoxicity in Fischer 344 and Sprague-Dawley rats. Toxicol. Sci. 2002; 67(2): 329-340.
57. Gartland KP, Bonner FW, Timbrell JA, Nicholson JK. Biochemical characterisation of para-aminophenol-induced nephrotoxic lesions in the F344 rat. Arch. Toxicol. 1989; 63(2): 97-106.
58. Gartland KP, Eason CT, Bonner FW, Nicholson JK. Effects of biliary cannulation and buthionine sulphoximine pretreatment on the nephrotoxicity of para-aminophenol in the Fischer 344 rat. Arch. Toxicol. 1990; 64(1): 14-25.
59. Elfarra AA, Jakobson I, Anders MW. Mechanism of S-(1,2-dichlorovinyl)glutathione-induced nephrotoxicity. Biochem. Pharmac. 1986; 35(2): 283-288.
60. Newton JF, Yoshimoto M, Bernstein J, Rush GF, Hook JB. Acetaminophen nephrotoxicity in the rat. II. Strain differences in nephrotoxicity and metabolism of p-aminophenol, a metabolite of acetaminophen. Toxicol. Appl. Pharmac. 1983; 69(2): 307-318.
61. Holmes E, Nicholson JK, Tranter G. Metabonomic characterisation of genetic variation in toxicological and metabolic responses using probabalistic neural networks. Chem. Res. Toxicol. 2001; 24: 182-191.
62. Gavaghan CL, Holmes E, Lenz E, Wilson ID, Nicholson JK. An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and A1pk:ApfCD mouse. FEBS Lett. 2000; 484(3): 169-174.
63. Griffin JL. Metabolic profiles to define the genome: can we hear the silent phenotypes. Phil. Trans. Biol. Sci. R. Soc. Lond. B 2004; 2: 1471-2970 on-line.
64. 1H nuclear magnetic resonance spectroscopic and pattern recognition study into dystrophic tissue. Anal. Biochem. 2001; 293(1): 16-21.
65. Bundy JG, Spurgeon DJ, Svendsen C, Hankard PK, Osborn D, Lindon JC, Nicholson JK. Earthworm species of the genus Eisenia can be phenotypically differentiated by metabolic profiling. FEBS Lett. 2002; 521(1-3): 115-120.
66. McIntosh LM, Garrett KL, Megeney L, Rudnicki MA, Anderson JE. Regeneration and myogerric cell proliferation correlate with taurine levels in dystrophin- and MyoD-deficient muscles. Anat. Rec. 1998; 252(2): 311-324.
67. Griffin JL, Williams HJ, Sang E, Nicholson JK. Abnormal lipid profile of dystrophic cardiac tissue as demonstrated by one- and two-dimensional magic-angle spinning (1)H NMR spectroscopy. Magn. Reson. Med. 2001; 46(2): 249-255.
68. 1H NMR of mdx mouse muscle and myoblast cells during fusion: evidence for a characteristic signal of long chain fatty acids. Neuromusc. Disord. 1993; 3(5-6): 433-438.
69. 1H-NMR detectable fatty acy1 chain unsaturation in excised leiomyosarcoma correlate with grade and mitotic activity. J. Clin. Invest. 1996; 98(2): 244-250.
70. Hintze TH, Shesely EG. Is a mouse like any other mouse? J. Mol. Cell Cardiol. 2002; 34(10): 1283-1286.
71. Linder CC. The influence of genetic background on spontaneous and genetically engineered mouse models of complex diseases. Lab. Anim. (NY) 2001; 30(5): 34-39.
72. Bendall JK, Heymes C, Wright TJ, Wheatcroft S, Grieve DJ, Shah AM, Cave AC. Strain-dependent variation in vascular responses to nitric oxide in the isolated murine heart. J. Mol. Cell Cardiol. 2002; 34(10): 1325-1333.
73. Hodgkinson A. Citric acid excretion in normal adults and in patients with renal calculus. Clin. Sci. 1962; 23: 203-205.
74. 1H NMR spectra of normal urines: reference ranges of the major metabolites. Clin. Chim. Acta 1997; 265(1):85-97.
75. 1H NMR spectroscopic and chemometric studies on endogenous physiological variation in rats. Ph.D. thesis, University of London, 2002; 43-67.
76. Bonate PL. Gender-related differences in xenobiotic metabolism. J. Clin. Pharmac. 1991; 31: 684-690.
77. Morishima HO, Abe Y, Matsuo M, Akiba K, Masaoka T, Cooper TB. Gender-related differences in cocaine toxicity in the rat. J. Lab. Clin. Med. 1993; 122(2): 157-163.
78. 1H NMR urinalysis studies on the biochemical effects of cadmium in the rat. Mol. Pharmac. 1989; 36(3): 398-404.
79. Muraoka Y, Itoh F. Sex difference of mercuric chloride-induced renal tubular necrosis in rats from the aspect of sex differences in renal mercury concentration and sulfhydryl levels. J. Toxicol. Sci. 1980; 5(3): 203-214.
80. Kattermann R, Sirowej H. Liver injury and lipid metabolism: sex differences in the fatty liver induced by d-galactosamine. Acta Hepatogastroenterol. (Stuttg.) 1979; 26: 112-121.
81. Kato R, Yamazoe Y. Sex-specific cytochrome P450 as a cause of sex and species related differences in drug toxicity. Toxicol. Lett. 1992; 64-65: 661-667.
82. Czerniak R. Gender-based differences in pharmacokinetics in laboratory animal models. Int. J. Toxicol. 2001; 20(3): 161-163.
83. Shapiro BH, Agrawal AK, Pampori NA. Gender differences in drug metabolism regulated by growth hormone. Int. J. Biochem. Cell. Biol. 1995; 1: 9-20.
84. Shiraga T, Iwasaki K, Takeshita K, Matsuda H, Niwa T, Tozuka Z, Hata T, Guengerich FP. Species- and gender-related differences in amine, alcohol and phenol sulphoconjugations. Xenobiotica 1995; 25(10): 1063-1071.
85. Joossen JV. Mechanisms of hypercholesterolemia and atherosclerosis. Acta Cardiol. Suppl. 1988; 29: 63-83.
86. Moser VC, Padilla S. Age- and gender-related differences in the time course of behavioral and biochemical effects produced by oral chlorpyrifos in rats. Toxicol. Appl. Pharmac. 1998; 149(1): 107-119.
87. Rikans LE, Hornbrook KR, Cai Y. Carbon tetrachloride hepatotoxicity as a function of age in female Fischer 344 rats. Mech. Ageing Dev. 1994; 76(2-3): 89-99.
88. Phipps AN, Stewart J, Wright B, Wilson ID. Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity. Xenobiotica 1998; 28(5): 527-537.
89. Fujita,S, Chiba M, Ohta M, Kitani K, Suzuki T, Alteration of plasma sex hormone levels associated with old age and its effect on hepatic drug metabolism in rats. J. Pharmac. Exp. Ther. 1990; 253(1): 369-374.
90. Vömel T, Platt D. Age-dependent phagocytosis of erythrocytes by the isolated perfused rat liver after galactosamine hepatitis and alpha-naphthylisothiocyanate cholestasis. Arch. Gerontol. Geriat. 1986; 5(4): 351-359.
91. Beckwith Hall BM. NMR spectroscopic studies on hepatotoxic processes. Ph.D. Thesis, University of London, 1998; 88-90.
92. Temellini A, Mogavero S, Giulianotti PC, Pietrabissa A, Mosca F, Pacifici GM. Conjugation of benzoic acid with glycine in human liver and kidney: a study on the interindividual variability. Xenobiotica 1993; 23(12): 1427-1433.
93. Guneral F, Bachmann C. Age-related reference values for organic acids in a healthy Turkish pediatric population. Clin. Chem. 1994; 40(6): 862-868.
94. Nordmann J, Nordmann R. Organic acids in blood and urine. Adv. Clin. Chem. 1961; 4: 53-120.
95. Wolfensohn S, Lloyd M. Handbook of Laboratory Management and Welfare, 2nd edn. Blackwell Science: Oxford, 1998; 170-217.
96. Schiebler TH, Danner KG. The effect of sex hormones on the proximal tubules in the rat kidney. Cell Tissue Res. 1978; 192(3): 527-549.
97. Davison JM, Hytten FE. The effect of pregnancy on the renal handling of glucose. Br. J. Obstet. Gynaecol. 1975; 82(5): 374-381.
98. Bishop JH, Green R. Effects of pregnancy on glucose handling by rat kidneys. J. Physiol. 1980; 307: 491-502.
99. Kishikawa T, Takahashi H, Shimazawa E, Ogata E. Diurnal changes in calcium and phosphate metabolism in rats. Horm. Metab. Res. 1980; 12: 545-551.
100. Zhang AQ, Mitchell SC, Smith RL. Exacerbation of symptoms of fish-odour syndrome during menstruation. Lancet 1996; 348(9043): 1740-1741.
101. Ayesh R, Mitchell SC, Smith RL. Dysfunctional N-oxidation of trimethylamine and the influence of testosterone treatment in man. Pharmacogenetics 1995; 5: 244-246.
102. Baker DEJ. Biology and disease. In The Laboratory Rat, Baker HJ, Lindsey JR, Weisbroth SH (eds). Academic Press: New York, 1979; 153-166.
103. Fujimura A, Ohashi, Ebihara A. Chronopharmacological study of furosemide; (VIII) influence of feeding restriction. Life Sci. 1991; 49(24): 1829-1834.
104. Roelfsema F, Van de Heide D, Smeenk D. Circadian rhythmns of urinary electrolyte excretion in freely moving rats. Life Sci. 1980; 27: 2303-2309.
105. Gavaghan CL, Nicholson JK, Connor SC, Wilson ID, Wright B, Holmes E. Directly coupled high-performance liquid chromatography and nuclear magnetic resonance spectroscopic with chemometric studies on metabolic variation in Sprague-Dawley rats. Anal. Biochem. 2001; 291(2): 245-252.
106. Bain MD, Jones M, Borriello SP, Reed PJ, Tracey BM, Chalmers RA, Stacey TE. Contribution of gut bacterial metabolism to human metabolic disease. Lancet 1988; 1(8594): 1078-1079.
107. Levin S, Semler D, Ruben Z. Effects of two weeks of feed restriction on some common toxicologic parameters in Sprague Dawley rats. Toxicol. Pathol. 1993; 21: 1-14.
108. Honglian S, Vigneau-Callahan KE, Shestopalov AI, Milbury PE, Matson WR, Kristal BS. Characterisation of diet-dependent metabolic serotypes: primary validation of male and female serotypes in independent cohorts of rats. J. Nutr. 2002; 132: 1039-1046.
109. Tucker SM, Mason RL, Beauchene RE. Influence of diet and feed restriction on kidney function of ageing male rats. J. Gerontol. 1976; 31: 264-270.
110. Ricketts WG, Birchenall-Sparks MC, Hardwick JP, Richardson A. Effect of age and dietary restriction on protein synthesis by isolated kidney cells. J. Cell. Physiol. 1985; 125: 492-498.
111. Rikimaru T, Oozeki T, Ichikawa M, Ebisawa H, Fujita Y. Comparisons of urinary creatinine, skeletal muscle mass and indices of muscle protein catabolism in rats fed ad libitum, with restricted food intake and deprived of food. J. Nutr Sci. Vitaminol. 1989; 35(3): 190-209.
112. Clausing P, Gottschalk M. Effects of drinking water acidification, restriction of water supply and individual cageing on parameters of toxicological studies in rats. Z. Versuchstierkd. 1989; 32(3): 129-134.
113. Panin LE, Starova TIu, Tret'iakova TA, Kolpakov AR, Kolosova IE, Solov'ev VN. Changes in glycolysis and glycogenolysis in tissues and level of certain hormones in blood and urine from rats with varying lengths of cold adaptation. Vopr. Med. Khim. 1995; 41(4): 14-18.
114. Harrison MH. Effects of acute heat stress on tissue carbohydrate in fasted rats. Aviation, Space Environ. Med. 1976; 47: 165-167.
115. Everson CA, Bergmann BM, Rechtschaffen A. Sleep deprivation in the rat: III. Total sleep deprivation. Sleep 1989; 12(1): 13-21.
116. Rechtschaffen A, Bergmann BM, Everson CA, Kushida CA, Gilliland MA. Sleep deprivation in the rat: X. Integration and discussion of the findings. Sleep 2002; 25(1): 68-87.
117. Tobler I, Murison R, Ursin R, Ursin H, Borbely AA. The effect of sleep deprivation and recovery sleep on plasma corticosterone in the rat. Neurosci. Lett. 1983; 35(3): 297-300.
118. Vander AJ, Sherman JH, Luciano DS. Human Physiology: the Mechanisms of Body Function, 6th edn. McGraw-Hill: New York, 1994; 515-560.
119. Schoenecker B, Heeler KE, Freimanis T. Development of sterotypes and polydipsia in wild caught bank voles (Clethionomys glareolus) and their laboratory-bred offspring. Is polydipsia a symptom of diabetes mellitus? Appl. Animal Behav. Sci. 2000; 68: 349-357.
120. Nicholls AW, Mortishire-Smith RJ, Nicholson JK. NMR spectroscopic and metabonomic studies of urinary metabolite variation in acclimatising germ free rats. Chem. Res. Toxicol. 2003; 16(11): 1395-1404.
121. Goodwin BL, Ruthven CRJ, Sandler M. Gut flora and the origin of some urinary aromatic phenolic compounds. Biochem. Pharmac. 1994; 47: 2294-2297.